Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chaudhary
Abhishek Chaudhary, Nagpur IN
| Patent application number | Description | Published |
|---|---|---|
| 20120137187 | SYSTEM AND METHOD FOR SCAN TESTING INTEGRATED CIRCUITS - A system for scan testing an IC includes one or more scan registers, one or more scan-in pads, one or more scan-out pads, and one or more comparators. Scan test data is transmitted from the scan-in pads to the scan registers. The functional response obtained from the scan test is transmitted to the comparator. The scan-out pad transmits the expected data to the comparator. The comparator compares the expected data and the functional response data and the comparison result is stored. The test result data is transmitted at positive and negative edges of the test clock signal. | 05-31-2012 |
| 20120246531 | SYSTEM AND METHOD FOR DEBUGGING SCAN CHAINS - Scan chains are used to detect faults in integrated circuits but with the size of today's circuits, it is difficult to detect and locate scan chain faults, especially when the scan data in and scan data out have been compressed. A method for debugging scan chains includes selecting a scan chain for debugging using a scan chain selection block and then providing scan test vectors to the selected scan chain. The scan test vectors undergo various scan test stages to generate scan response vectors. The scan response vectors are compared with ideal response vectors to identify a failing scan chain. | 09-27-2012 |
Alka Chaudhary, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20090263333 | Pharmaceutical compounds and compositions - The invention provides three polymorphic forms of crystalline levosalbutamol sulphate designated herein as Forms I, II and III. Crystalline levosalbutamol sulphate Form I is characterised by a powder XRD pattern with peaks at 10.8, 11.9, 13.0, 18.3, 28.5±0.2 degrees 2 theta. Crystalline levosalbutamol sulphate Form II is characterised by a powder XRD pattern with peaks at 8.7, 9.6, 15.2, 15.7, 19.1, 27.2, 30.7±0.2 degrees 2 theta. Crystalline levosalbutamol sulphate Form III is characterised by a powder XRD pattern with peaks at 5.5, 6.9, 7.3, 18.7±0.2 degrees 2 theta. Processes for making the new polymorphic forms and pharmaceutical compositions comprising them are also provided. A pharmaceutical composition comprises a therapeutically effective isomer of salbutamol or a salt, solvate, ester, derivative or polymorph thereof, a glucocorticoid and a pharmaceutically acceptable carrier or excipient and optionally one or more other therapeutic agents. Preferably the composition is an aerosol formulation comprising the drugs, a propellant and optionally one or more other ingredients, such as a surfactant, cosolvent, or bulking agent. Alternatively, DPI or inhalation suspensions may be used. | 10-22-2009 |
Alka Chaudhary, Panvel IN
| Patent application number | Description | Published |
|---|---|---|
| 20090325915 | Crystalline Levosalbutamol Sulphate and Polymorphic Forms Thereof - The invention provides three polymorphic forms of crystalline levosalbutamol sulphate designated herein as Forms I, II and III. | 12-31-2009 |
Anita Chaudhary, Gandhinagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20120046317 | NOVEL HETEROCYCLIC COMPOUNDS - The present invention relates to a new class of heterocyclic compounds and pharmaceutically acceptable salts thereof, process for preparing the same, pharmaceutical composition containing these compounds and to their use in treatment of diseases caused due to formation and accumulation of AGEs (Advanced Glycation end products). The compounds of the present invention are useful for the treatment of diabetic and aging-related complications caused by formation and accumulation of AGEs, such as neuropathy, nephropathy, microangiopathy, retinopathy, hypertension, heart failure, atherosclerosis, Alzheimer's disease & dermatological disorders. | 02-23-2012 |
Anita Chaudhary, Gujarat IN
| Patent application number | Description | Published |
|---|---|---|
| 20090088432 | Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors - The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specification. The invention also encompasses process for preparing such compound, pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases. | 04-02-2009 |
Ashish Chaudhary, Edmonton CA
| Patent application number | Description | Published |
|---|---|---|
| 20080236837 | COMMUNICATING MEASUREMENT DATA FROM A WELL - To communicate measurement data from a well, data corresponding to measurement data collected by multiple sensors in a well is transformed downhole and passed to an intermediate communications device, which device in turn passes a subset of that data to a destination communications device. The destination communications device applies a second transformation to the data received from the intermediate communications device. The first and second transformations are designed such that meaningful data can be recovered at the destination communications device even though only a subset of the original transformed data has been received. | 10-02-2008 |
| 20120181050 | METHOD AND APPARATUS FOR SETTING A PACKER - A hydraulically set packer assembly actuated over an electronic line. The assembly includes a hydraulic packer setting mechanism that serves as an intensifier that is activated by way of an electronic trigger. As such, the trigger may be electronically coupled to an electronic line that is conventionally available for surface communications between surface equipment and a downhole gauge. The gauge generally present for monitoring well conditions such as pressure. Thus, a separate dedicated hydraulic or other powering line need not be outfitted as part of the assembly. Once more, for sake of gauge and well monitoring integrity, communications with the setting mechanism may be severed upon setting of the packer. | 07-19-2012 |
Ayesha Chaudhary, Karnal IN
| Patent application number | Description | Published |
|---|---|---|
| 20110262363 | GLUCOSE BIOSENSOR SYSTEM COUPLED WITH AN ANTI-INFLAMMATORY MODULE AND METHODS FOR USING THE SAME - Disclosed are apparatuses for detecting glucose levels in a subject. The apparatuses include a glucose sensor coupled with an anti-inflammatory module. The apparatus is configured to monitor blood glucose by detecting the fluorescence generated by the sensor and simultaneously reduce the tissue inflammation reaction. Also disclosed are biosensor systems including the apparatuses and methods of using the biosensor systems. | 10-27-2011 |
Devendra Chaudhary, Oberschan CH
| Patent application number | Description | Published |
|---|---|---|
| 20130052369 | PLASMA REACTOR - A plasma reactor with a recipient ( | 02-28-2013 |
Latha Chaudhary, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20110206788 | NOVEL HERBAL COMPOSITION - Disclosed herein is synergistic herbal composition comprising extracts of herbal ingredients of | 08-25-2011 |
Manu Chaudhary, Panchkula IN
| Patent application number | Description | Published |
|---|---|---|
| 20090318378 | Antibiotic Combinations For Providing Total Solution to the Treatment of Infections - The invention relates to a new pharmaceutical composition, a method of treatment of infection and also a process to prepare the composition. The infectious complications are important causes of morbidity and mortality. Hospital acquired pneumonia (HAP) remains the most severe nosocomial infection in intensive care units. Beta-lactams alone are always considered inadequate when | 12-24-2009 |
| 20110257079 | Parenteral Combination Therapy for Infective Conditions With Drug Resistant Bacterium - The invention describes a pharmaceutical composition to combat multiple-drug-resistant bacteria in non-ocular infective conditions. Compositions comprising glycopeptides, in particular vancomycin, and cephalosporins, in particular ceftriaxone, are disclosed. Such compositions are found to be useful for parenteral administration for hospitalized patients with serious infections. Specifically, this invention also discloses a pharmaceutical composition further including an excipient such as CVMC agent and is available in dry powder form for reconstitution before injection with a suitable solvent. The pharmaceutical compositions of this invention have been found normally to enhance resistance to precipitation in solutions to be administered parenterally. The invention also gives details of the dosage forms stored in sealed containers to be reconstituted before use. The invention further provides a process to manufacture these compositions and also a method of treating a subject having non-ocular infective conditions due to multi drug resistant bacterium. | 10-20-2011 |
| 20110262499 | TOPICAL HERBAL FORMULATION FOR TREATMENT OF ACNE AND SKIN DISORDERS - The present invention provides novel herbal nano emulsion based formulations comprising a combination of lemon juice and/or rose water as therapeutically active aqueous phase entrapped in oil phase selected from one or more essential oils and process for the preparation of the same in pharmaceutically acceptable dosage forms for topical treatment of acne and other skin disorder like eczema, psoriasis, aging scaring and the like with increased efficacy, Improved percutaneous penetration, excellent thermodynamic stability ensuring long shelf life, low skin irritation and reservoir effect that promotes drug localization in the skin enabling controlled delivery of the said therapeutic agents. | 10-27-2011 |
| 20120093888 | MICRO-EMULSIONS FOR THE TREATMENT OF RHEUMATIC DISORDERS - A formulation to treat rheumatic disorders and related infections is provided. The formulation is a micro-emulsion including at one or more of an active ingredients. The active ingredient includes one or more of an essential oil mixed with an aqueous phase along with one or more of a surfactant and one or more of a co-surfactant. The co-surfactant is medicated by an extract of one or more of an herb. | 04-19-2012 |
Manu Chaudhary, Haryana IN
| Patent application number | Description | Published |
|---|---|---|
| 20080227732 | Treatment and Control of Severe Infections Including Cystic Fibrosis - The present invention provides a pharmaceutical composition comprising antibiotic combination products for delivering two or more different antibiotics simultaneously, wherein the two different antibiotics comprise one which consisting of concentration dependent killing and the other concentration independent killing or time dependant killing activity. The invention has been worked out utilizing pharmacokinetic and pharmacodynamic principles to optimize antibiotic regimen, to improve clinical results and to potentially decrease the development of resistance. Combination of ceftazidime and tobramycin has been evolved to specifically illustrate the invention. | 09-18-2008 |
| 20090156670 | NONAQUEOUS LIQUID PARENTERAL ACECLOFENAC FORMULATION - A nonaqueous liquid parenterally deliverable pharmaceutical formulation, and more particularly a nonaqueous liquid parenteral Aceclofenac formulation comprising the selective NSAID Aceclofenac, is disclosed. A process of preparing Aceclofenac formulation, the therapeutic dosage form and storage of dose, and the method of treating a subject having a condition or a disorder wherein treatment with NSAID is indicated, are also disclosed. Diclofenac formed by conversion of Aceclofenac is solubilized by the nonaqueous solubilizer(s), which are substantially inert with respect to such conversion. The composition has Aceclofenac salt stabilizing means for inhibiting precipitation of Aceclofenac. The compositions disclosed in the present invention are stable upon storage at room temperature and at refrigerated temperatures. Compositions disclosed in the present invention, whether ready-to-use or requiring dilution prior to administration, can be prepared by inexpensive processes disclosed herein. | 06-18-2009 |
| 20100160277 | COMPOSITIONS FOR COMBATING BETA-LACTAMASE-MEDICATED ANTIBIOTIC RESISTANCE USING BETA-LACTAMASE INHIBITORS USEFUL FOR INJECTION - The invention describes a composition for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitor useful for injection, capable of pharmaceutical application. The invention relates to pharmaceutical composition containing ceftriaxone (normally as ceftriaxone sodium) and sulbactam (normally as sulbactam sodium). Such compositions are found to be useful for intramuscular or intravenous administration as antibiotics for hospitalized patients with serious infections. Specifically, this invention relates to a pharmaceutical composition further including an aminocarboxylic acid chelating agent, for example, ethylenediaminetetraacetic acid (EDTA), or a pharmaceutically acceptable salt thereof. The pharmaceutical compositions of this invention have been found normally to enhance resistance to particulate formation in solutions to be administered parenterally. The invention also gives details of the dosage forms stored in sealed containers to be reconstituted before use. The invention also gives a process to manufacture these compositions. The invention gives a method of treating a subject having a condition or disorder, wherein a treatment with ceftriaxone sodium and sulbactam sodium is indicated. | 06-24-2010 |
| 20110186457 | NOVEL SINGLE UNIT CARBAPENEM AMINOGLYCOSIDE FORMULATIONS - A pharmaceutical low dose, antibiotic combination of two antibiotics selected from a carbapenem and an aminoglycoside, present as a single unit fixed low dose injection effective at very low concentrations. The antibiotic combination is suitable for the treatment of bacterial/multibacterial infections, and is particularly suitable for neonates, children, and other patients with low tolerance, and who are prone to serious fatal mixed multi-bacterial infectious diseases where potential toxicity due to higher doses is a cause for concern. | 08-04-2011 |
Nitin Chaudhary, Edinburgh GB
| Patent application number | Description | Published |
|---|---|---|
| 20120116677 | ASSISTED POSITIONING SYSTEMS - A position determining unit has an assistance data processing and relaying module (software client) ( | 05-10-2012 |
Nveed Chaudhary, Middlesex GB
| Patent application number | Description | Published |
|---|---|---|
| 20090048267 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 02-19-2009 |
Nveed Chaudhary, Southampton GB
| Patent application number | Description | Published |
|---|---|---|
| 20100204211 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 08-12-2010 |
| 20110076238 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES - The invention relates to the use of anticholinergics for preparing a pharmaceutical composition for the prevention and treatment of proliferative processes. | 03-31-2011 |
| 20120004202 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 01-05-2012 |
Parveen Kumar Chaudhary, Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110202393 | INTEGRATED SYSTEM AND METHOD FOR CAR POOLING USING SMART CARDS, GPS, GPRS, ACTIVE POSTER AND NEAR FIELD COMMUNICATION DEVICES - A method, integrated system and in-vehicle Active Poster for processing mobile touch transactions including carpooling transactions. The integration includes a near field contactless or swipe smart card or other portable identification device which may be standalone, affixed to, or part of a mobile or hand held portable wireless communication device, a touch sensitive Active Poster also with swipe or near field contactless communication capability and also incorporating or in communication with GPS or other vehicle location services capability for the vehicle, a car pool management or other service provider's system and application and a host computer with networking capability. | 08-18-2011 |
| 20110202417 | INTEGRATED SYSTEM AND METHOD FOR ENABLING MOBILE COMMERCE TRANSACTIONS USING ACTIVE POSTERS AND CONTACTLESS IDENTITY MODULES - A method, integrated system and Active Poster for processing mobile touch transactions. The integration consists of an RFID or other near field communication enabled device which may be standalone, affixed to, or part of a mobile or hand held portable wireless communication device (optionally using a Contact Less (CL) SIM with near field communication capability), a touch sensitive Active Poster also with near field communication capability, an issuer's or mobile network provider's system and application and a host computer with networking capability. | 08-18-2011 |
Preeti Madhukar Chaudhary, Pune IN
| Patent application number | Description | Published |
|---|---|---|
| 20120225877 | SUBSTITUTED 1, 4-DIOXA-8-AZASPIRO[4,5]DECANES USEFUL AS FUNGICIDES AND A PROCESS FOR THE PREPARATION THEREOF - This invention relates provides novel substituted 1,4-dioxa-8-azaspiro[4,5]decane of general formula (1), wherein R1 is selected from phenethyl, 4,6-dimethoxypyrimidin-2-yl and (2-chloro-5-thiazolyl)methyl and R2 is selected from the group consisting of hydroxy, 4-bromo-2-chlorophenoxy, morpholin-4-yl, (2-chloro-5-thiazolyl)methyloxy, benzyloxy, phenylsulfanyl, benzotriazol-1-yl and 5-chloro-2-fluoroanilino. The present invention also relates to a process for the preparation of novel substituted 1,4-dioxa-8-azaspiro[4,5]decanes of general formula (1). The novel substituted 1,4-dioxa-8-azaspiro[4,5]decane of general formula (1) has fungicidal activity. | 09-06-2012 |
Sanjay Kumar Chaudhary, Aalborg DK
| Patent application number | Description | Published |
|---|---|---|
| 20100219838 | METHOD OF DETECTING THE WET ARC FAULT IN THE AC POWER DISTRIBUTION APPLICATIONS - Methods for detecting wet arc faults are based on the direct current (DC) signature analysis and pattern matching pertaining to wet arc characteristics. While magnifying some wet arc fault signatures, it may be found that the wet arc current signal itself resembles a normal current signal in both time and frequency domains. The change in magnitude or high frequency behavior found may not be enough to distinguish a wet arc fault signature from a normal signature. Embodiments of the present invention may look at the magnitude change in the DC content per cycle of the wet arc current signal, which may be more positive in one cycle while, in the next cycle, it may be negative in a relative manner. A particular number of these changes may be determinative of a wet arc fault. | 09-02-2010 |
| 20100259859 | METHOD OF ENSURING THE COORDINATED ARC FAULT PROTECTION IN A HEIRARCHIAL POWER DISTRIBUTION SYSTEM - A coordinated arc fault protection scheme in a hierarchical power distribution system is disclosed. The methods according to embodiments of the present invention may be considered an “event and time graded” analysis. In event and time based analysis, the number of confirmed arc signature may be monitored with respect to time in the main feeder line as well as the branched feeders. The confirmed arc signature in the branched feeder, as well as in the main feeder, may be captured and time stamped. A trip command may be issued first in the intended branched feeder if the branched feeder experiences a minimum number of events within a given time. During the same time period, the main feeder also monitors similar arcing events. If the tripping of the branched feeder occurs and the main feeder still detects arcing events, the main feeder may be tripped after a certain period of time or a certain number of confirmed arc signature. If there is no arc in the branched feeder and the main feeder itself experiences the arc, then the main feeder may be tripped after a predetermined period of time so that the current to all the branched feeders may be cut and the main feeder may be protected. | 10-14-2010 |
Sanjay Kumar Chaudhary, Mississauga CA
| Patent application number | Description | Published |
|---|---|---|
| 20090147414 | GROUND FAULT DETECTION IN AN UNGROUNDED ELECTRICAL SYSTEM - An ungrounded electrical power distribution system may experience a single line to ground fault. Such a fault may not disrupt operation of the system, but its presence may raise a risk of additional problems if left uncorrected. A system for progressively grounding the ungrounded system may be initiated when a line to ground fault is suspected. As grounding through successively lower impedance proceeds, fault current may increase and detection of severity of the line to ground fault may be more readily achieved, thus facilitating localization of the fault. | 06-11-2009 |
| 20090147415 | GROUND FAULT DETECTION AND LOCALIZATION IN AN UNGROUNDED OR FLOATING DC ELECTRICAL SYSTEM - An ungrounded or floating DC electrical power distribution system may experience a single line to ground fault. Such a fault may not disrupt operation of the system, but its presence may raise a risk of additional problems if left uncorrected. A system for progressively grounding the ungrounded system may be initiated when a line to ground fault is suspected based on the voltage difference measured to a common chassis point. As grounding through successively lower impedance proceeds, fault current may increase and detection of severity of the line to ground fault may be more readily achieved, thus facilitating localization of the fault. Localization may be achieved through an analysis of direction of capacitive currents in isolatable zones of the system. | 06-11-2009 |
Sartaj Chaudhary, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20120027064 | Identifying Rogue GSM Base Stations by Intercepting Downlink Beacon Channels - System and methods and memory media for identifying a rogue base station. A receiver captures an input signal that includes a mixture of the rogue station's transmission and the transmission of a victim base station. The victim station's transmission is removed from the mixture. A plurality of channel signals are extracted from the residual signal. The channel signals are analyzed which of them are “valid”, i.e., contain a GMSK-modulated GSM signal. The “valid” channel signals are low pass filtered and then analyzed to determine which of them corresponds to the beacon channel. Information identifying the rogue base station is extracted from the beacon channel. | 02-02-2012 |
Uma Chaudhary, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20100311049 | PCR-Based Kit For Detecting Chlamydia Trachomatis and Nelsseria Gonorrhoeae - The invention relates to a PCR based prototype kit for detecting | 12-09-2010 |